Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer

Chemotherapy

Volumn 47, Issue 6, 2001, Pages 444-451

  Sakamoto, Masahiro ^a   Mikasa, Keiichi ^a   Majima, Toshimasa ^a   Hamada, Kaoru ^a   Konishi, Mitsuru ^a   Maeda, Koichi ^a   Kita, Eiji ^a   Narita, Nobuhiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cachexia; Clarithromycin; Interleukin 6; Non small cell lung cancer

Indexed keywords

ALBUMIN; CHOLINESTERASE; CISPLATIN; CLARITHROMYCIN; HEMOGLOBIN; INTERLEUKIN 6; MITOMYCIN; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VINDESINE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BODY WEIGHT; CACHEXIA; CARCINOMA, NON-SMALL-CELL LUNG; CLARITHROMYCIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN SYNTHESIS INHIBITORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0035688430     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048556     Document Type: Article

References (21)

1. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation
2. Evaluation of the immunostimulating activity of erythromycin in man
3. Effect of erythromycin on cellular and humoral immune functions in vitro and in vivo
4. Immunological and anti-inflammatory effects of clarithromycin: Inhibition of interleukin 1 production of murine peritoneal macrophage
5. Chemotherapy vs supportive care in advanced non-small cell lung cancer
6. Polychemotherapy in advanced non-small cell lung cancer
7. Chemotherapy for advanced non-small cell lung cancer
8. Studies of endotoxin-induced decrease in lipoprotein lipase activity
9. Identity of tumor necrosis factor and the macrophage-secreted factor, cachectin
10. Cachectin/TNF induces cachexia, anemia and inflammation
11. Evidence for the involvement of interleukin 6 in experimental cancer cachexia
12. Mechanism of experimental cancer cachexia
13. Significant survival benefit to patients with advanced non-small cell lung cancer from treatment with clarithromycin
14. Reporting results of cancer treatment
15. Cancer - Appraisal of methods for the study of chemotherapy of cancer in men: Thiophosphoramide
16. Long-term clarithromycin treatment for cancer cachexia of inoperable non-small cell lung cancer patients
17. Serum levels of interleukin 6 in patients with lung cancer
18. Antiinflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors
19. Antitumor effect of erythromycin in mice
20. Long-term chemotherapy using erythromycin for chronic lower airway infection. IV. Efficacy of clarithromycin for treatment of patients unresponsive to erythromycin
21. Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer